The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2024

Filed:

Apr. 20, 2022
Applicant:

Wuhan University, Wuhan, CN;

Inventors:

Juan Liu, Wuhan, CN;

Yuqi Chen, Wuhan, CN;

Jing Feng, Wuhan, CN;

Assignee:

WUHAN UNIVERSITY, Wuhan, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/00 (2017.01); G06T 7/11 (2017.01); G06V 10/764 (2022.01); G06V 10/774 (2022.01); G06V 10/82 (2022.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01);
U.S. Cl.
CPC ...
G06T 7/0012 (2013.01); G06T 7/11 (2017.01); G06V 10/764 (2022.01); G06V 10/774 (2022.01); G06V 10/82 (2022.01); G16H 30/40 (2018.01); G16H 50/20 (2018.01); G06T 2207/10056 (2013.01); G06T 2207/20036 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01); G06T 2207/30024 (2013.01); G06T 2207/30068 (2013.01); G06T 2207/30096 (2013.01); G06V 2201/03 (2022.01);
Abstract

Provided is a method and system for predicting tumor mutation burden (TMB) in triple negative breast cancer (TNBC) based on nuclear scores and histopathological whole slide images (WSIs). The method includes the following steps: first, screening the histopathological WSIs of TNBC; calculating a TMB value of each patient according to gene mutation of each patient with TNBC, and dividing the TMB values into two groups with high and low TMB according to a set threshold; dividing the histopathological WSIs of TNBC into patches of a set size; screening a certain number of patches with high nuclear scores according to a nuclear score function; then building a convolutional neural network (CNN) classification model, and stochastically initializing parameters in the CNN classification model; and finally, putting the screened patches into the built CNN classification model for training, so as to automatically predict high or low TMB with the histopathological WSIs of TNBC.


Find Patent Forward Citations

Loading…